Neogenix Oncology Inc
company.status.inactiveCIK 1341293fmd_19S4Y5A2YS3P77587J1RXW6C4TManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2004 to Dec 31, 2011, 12 periods
Latest annual · FY2011
Millions- Operating income
- (20)
- Net income
- (19)
- Free cash flow
- (8)
Latest quarter · Q4 FY2011
Millions- Operating income
- (3)
- Net income
- (3)
- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2006 to FY2011
- n/m
Neogenix Oncology Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2011 | FY2010 | Change | Source |
|---|---|---|---|---|
| Operating income | -$19.7 million | -$19.6 million | 10-K 2012-07-12 · proof | |
| Net income | -$19 million | -$19.1 million | 10-K 2012-07-12 · proof | |
| Cash from operating activities | -$8.4 million | -$13.6 million | 10-K 2012-07-12 · proof | |
| Free cash flow | -$8.4 million | -$14 million | 10-K 2012-07-12 · proof | |
| Total assets | $6.3 million | $12.9 million | -50.8% | 10-K 2012-07-12 · proof |
| Total liabilities | $2.3 million | $1.6 million | +48.4% | 10-K 2012-07-12 · proof |
| Cash and cash equivalents | $3 million | $3.2 million | -7.2% | 10-K 2012-07-12 · proof |
- What was Neogenix Oncology Inc's operating income in fiscal 2011?
- Neogenix Oncology Inc reported operating income of -$19.7 million for fiscal 2011 (the year ended Dec 31, 2011), against -$19.6 million the year before. Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What was Neogenix Oncology Inc's net income in fiscal 2011?
- Neogenix Oncology Inc reported net income of -$19 million for fiscal 2011 (the year ended Dec 31, 2011), against -$19.1 million the year before. Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What was Neogenix Oncology Inc's cash from operating activities in fiscal 2011?
- Neogenix Oncology Inc reported cash from operating activities of -$8.4 million for fiscal 2011 (the year ended Dec 31, 2011), against -$13.6 million the year before. Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What was Neogenix Oncology Inc's free cash flow in fiscal 2011?
- Neogenix Oncology Inc reported free cash flow of -$8.4 million for fiscal 2011 (the year ended Dec 31, 2011), against -$14 million the year before. Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What are Neogenix Oncology Inc's total assets?
- As of Dec 31, 2011, Neogenix Oncology Inc reported total assets of $6.3 million, against $12.9 million a year earlier (-50.8%). Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What are Neogenix Oncology Inc's total liabilities?
- As of Dec 31, 2011, Neogenix Oncology Inc reported total liabilities of $2.3 million, against $1.6 million a year earlier (+48.4%). Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
- What are Neogenix Oncology Inc's cash and cash equivalents?
- As of Dec 31, 2011, Neogenix Oncology Inc reported cash and cash equivalents of $3 million, against $3.2 million a year earlier (-7.2%). Source: the 10-K filed with the SEC on Jul 12, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1341293&period_type=annual&limit=5"Information only, not investment advice.